Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)
Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –
Veracyte total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Veracyte's total debt was $0 at Dec 31, 2022. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $25.28M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $1.13M | +39.1% |
| FY2020 | Dec 31, 2020 | $810.00K | +16.7% |
| FY2019 | Dec 31, 2019 | $694.00K | -97.3% |
| FY2018 | Dec 31, 2018 | $25.28M | +1.4% |
| FY2017 | Dec 31, 2017 | $24.94M | +0.1% |
| FY2016 | Dec 31, 2016 | $24.92M | +399.4% |
| FY2015 | Dec 31, 2015 | $4.99M | +1.4% |
| FY2014 | Dec 31, 2014 | $4.92M | +0.5% |
| FY2013 | Dec 31, 2013 | $4.90M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.19M | +10.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.13M | +23.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.08M | +25.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.13M | +39.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.08M | +42.2% |
| Q2 FY2021 | Jun 30, 2021 | $917.00K | +14.5% |
| Q1 FY2021 | Mar 31, 2021 | $863.00K | +15.4% |
| Q4 FY2020 | Dec 31, 2020 | $810.00K | +16.7% |
| Q3 FY2020 | Sep 30, 2020 | $756.00K | +18.3% |
| Q2 FY2020 | Jun 30, 2020 | $801.00K | +36.9% |
| Q1 FY2020 | Mar 31, 2020 | $748.00K | -94.2% |
| Q4 FY2019 | Dec 31, 2019 | $694.00K | -97.3% |
| Q3 FY2019 | Sep 30, 2019 | $639.00K | -97.5% |
| Q2 FY2019 | Jun 30, 2019 | $585.00K | -97.7% |
| Q1 FY2019 | Mar 31, 2019 | $12.85M | -48.6% |
| Q4 FY2018 | Dec 31, 2018 | $25.28M | +1.4% |
| Q3 FY2018 | Sep 30, 2018 | $25.19M | +0.8% |
| Q2 FY2018 | Jun 30, 2018 | $25.10M | +0.5% |
| Q1 FY2018 | Mar 31, 2018 | $25.02M | +0.3% |
| Q4 FY2017 | Dec 31, 2017 | $24.94M | +0.1% |
| Q3 FY2017 | Sep 30, 2017 | $25.00M | +0.4% |
| Q2 FY2017 | Jun 30, 2017 | $24.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $24.94M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.92M | – |
| Q3 FY2016 | Sep 30, 2016 | $24.89M | – |
See a number that looks wrong?